Does anyone know if a woman does some anavar or a small amount of test , does it take away from the effectiveness of the pill?
Does anyone know if a woman does some anavar or a small amount of test , does it take away from the effectiveness of the pill?
Originally Posted by djack99587
I would be interested in knowing this myself. I have researched a lot and cannot find the answer. Unfortunately I don't have access to a PDR right now or I would look it up for you. The best I could find is this:
http://health.yahoo.com/drug/d00566a1
It's a definate no-no to take if you (she) are pregnant. But I could not find anything on birth control.
Oh, on that note, I did learn that there are some migraine medicines that cancel out birth control. Yup, I was shocked too. But I have a 6 month old girl to prove it.
That athat was.
Anyway, the best I could find was this:
http://clinicaltrials.gov/ct/gui/sho...5AB4F?order=48
Its a clinical trial done on oxandrolone. In the eligibility criteria it states that if you are of child bearing potential, you must agree to use a medically approved birth control. (because oxadrolone does cause birth defects) So logic would make me think that it would have no affect on birthcontrol. But that is far from conclusive proof.
Thats all I could find. But the search yeilded me with tons of information reguarding the clinical use of Anavar. Clinical? WOW, I didn't know there was a "professional" use for this stuff in the medical world.![]()
they work agenst each other. She should not be on the pill in teh first place if running var. Women also should not run test.
what kind of pill is she takeing?
she takes loestren , not sure if its spelled right...... i thought women could take low doses of test as hormone therapy, "fat loss , increased libido" was reading steroid. coms new hrt..... if anyone knows the answer if birth control will be cncelled out please let me know
Loestrin 24 Fe contain a combination of the female hormones estrogen and progesterone.
There for no she can not take var or test when on. The body is tricked into thinking she is prrgnet from this pill. The var will be working agenst the pill and be less effective for both of them.
As for women on test. this is no for an injectable test. Women for libdio probelms go on a test patch. Thois is a very little does like 2mg and day.
Understanding the causes of Low Female Libido and female sexual dysfunction:
1. Psychological/Mental -- The causes of psychological sexual dysfunction and low female libido are numerous, and it is difficult to list them all, but most often low female libido is related to anxiety, stress, depression, marital or relationship problems, life crisis, financial difficulties, religious repression, or some form of mental illness.
2. Hormonal -- Androgens, such as testosterone, are a major component of female libido. Testosterone levels decline about 1 percent each year in men, which may contribute to lower male libido with aging. Testosterone also declines with age in women leading to a decrease in female libido. Women who have had surgical removal of the ovaries notice a drop in sexual interest. Replacement of androgens can be helpful in those with age related sexual dysfunction. Testosterone is available by prescription only. An over the counter hormones, such as DHEA, converts into testosterone and thus has a positive influence on libido. Pregnenolone is another over the counter hormone that may increase testosterone levels and thus enhance female libido. However, the risk of side effects and potential long term health consequences of testosterone must be taken into account. My preference is to avoid hormones unless absolutely necessary and instead use herbal supplements for libido enhancement. These herbal libido boosters are extremely effective.
3. Vascular -- Alterations in the flow of blood to and from the genital region are a minor cause of female sexual dysfunction. For instance, medical conditions such as atherosclerosis (hardening of the arteries), high cholesterol, hypertension, or diabetes reduce blood flow to the genital organs. An additional factor that can impede blood flow is surgery in the pelvic or a**ominal area.
4. Neural -- Nerve damage from disorders such as diabetes, multiple sclerosis, Parkinson’s disease, and stroke affect the brain’s ability to respond to sexual stimulation. In women, a**ominal or pelvic operations can occasionally lead to nerve damage.
5. Chemical -- Some chemicals involved in the human sexual response include dopamine, acetylcholine, and nitric oxide. Certain medications and drugs interfere with the proper activity of the body's chemicals and hormones responsible for female libido
Female Libido and Medical conditions
Certain medical conditions reduce female libido, performance, or enjoyment. These include hypertension, diabetes, high cholesterol, cardiovascular disease, peripheral vascular disease, and neurologic disorders, and insomnia.
Drugs and Female Libido
Drugs that interfere with sexual function include some anti-hypertensives, SSRIs, sedatives, and beta-blockers. Alcohol's negative affect on a woman's libido increases with age. Smoking can reduce genital blood flow.
Some Basic Ways To Enhance Female Libido
Physical fitness positively influences female sexual desire and performance.
Deep sleep is crucial for optimum female sexual function.
Eat more cold water fish for their content of fish oils.
Do yoga, stretching, or relaxation exercises.
Keep an open mind and try to be non-judgmental.
Consider natural herbs, many really work.
Does Viagra help with female libido?
Viagra (sildenafil), approved by the FDA in 1998, has been the most popular medicine for the treatment of erectile dysfunction. Viagra works very well in dilating blood vessels in the genital region leading to an erection in men, however it does little to directly increase female libido or sexual arousal. New studies in women show Viagra not to be effective. Side effects of Viagra include headache, flushes, nasal congestion or runny nose, malaise, nausea, changes in blood pressure, irregular heart beats, visual disturbances including rare cases of blindness, and chest pain. Viagra may cause stickiness of blood platelets. Most of my women patients find natural libido boosters quite effective and preferable to pharmaceutical drugs.
Testosterone and Female libido
Treatment with a patch containing the hormone testosterone can increase libido in women who experience reduced libido after surgical removal of the ovaries.
Female Libido Research Update
Women with low female libido: correlation of decreased androgen levels with female sexual function index.
Int J Impotence Res. 2004 Dec 09;
The aim of the present study was to investigate a possible correlation between decreased androgen levels and female sexual function index (FSFI) in women with low female libido and compare these findings with normal age-matched subjects. In total, 20 premenopausal women with low libido (mean age 36.7; range 24-51 y) and 20 postmenopausal women with low libido (mean age 54; 45-70 y), and 20 premenopausal healthy women (mean age 32.2; range 21-51 y) and 20 postmenopausal healthy women (mean age 53.5; range 48-60 y) as controls were enrolled in the current study. Women with low libido had symptoms for at least 6 months and were in stable relationships. All premenopausal patients had regular menstrual cycles and all postmenopausal patients and controls were on estrogen replacement therapy. None of the patients were taking birth control pills, corticosteroids or had a history of chronic medical illnesses. We found significant differences between the women with low female libido and the controls in total testosterone, free testosterone and DHEA-S levels and full-scale FSFI score for both pre- and postmenopausal women. Our data suggest that women with low female libido have lower androgen levels compared to age-matched normal control groups and their decreased androgen levels correlate positively with female sexual function index domains.
Androgen status in healthy premenopausal women with loss of libido.
J Sex Marital Ther. 2005 Jan-Feb;31(1):73-80.
Androgen deficiency may contribute to female sexual dysfunction and loss of female libido. The role of the active metabolite of testosterone, dihydrotestosterone (DHT), in these conditions is uncertain. The aim of this study was to determine the role of androgens and DHT in the etiology of loss of libido in healthy women. Conclusion: Loss of female libido in otherwise healthy women may be related to relationship problem, depression, psychosocial factors, and sexual dysfunction in the partner but do not appear to be related to androgen status.
Medical management of male and female libido disturbances in treated hypertensive patients: differences between men and women.
Arch Mal Coeur Vaiss. 2003 Jul-Aug;96(7-8):758-62
Decrease in male and female libido is a disturbance affecting treated hypertensive subjects of both sexes. In contrast with erection problems, low libido has rarely been studied in hypertensives treated with antihypertensive drugs. OBJECTIVES: To evaluate, using a self-administered questionnaire, the prevalence of male and female libido disturbance (decrease in sexual desire) in treated hypertensive subjects and to determine the management of these troubles. METHODS: In 428 hypertensive subjects, living in France and referred to hypertension specialists, a self-administered questionnaire evaluating the quality of sexual activity was given before the consultation. Nine specific questions focused on the quality of libido for the last 6 months in men or women (interest for sexuality, female libido , sexual pleasure). Secondly, the doctors were questioned about their management of these female libido disturbances. RESULTS: In this population of treated hypertensives, including 270 men and 158 women, with a blood pressure level of 139 mmHg, a decrease in male and female libido was reported by 47% of men and 48% of women. Libido disturbance was related to antihypertensive drugs in 46% of cases, more often in men (59%) than in women (24%). In subjects with libido disturbance, a specific medical management has been proposed in 35% of cases, especially in men (in 46% of cases, and consisted in a specialized consultation for 34% and/or the prescription of Sildenafil for 20%. In women, the lack of management of these female libido troubles was more often observed than in men (82% vs 54%). Modifications of antihypertensive treatments were rarely observed in 15% of cases comparatively in men and women. CONCLUSIONS: Men and women with treated hypertension are at "high risk" of male and female libido disturbance. Management of male and female libido dysfunction in these subjects concerns only 35% of cases, especially men, including specific treatments and/or consultations, but changing in antihypertensive drugs still remains rare.
Acute dehydroepiandrosterone (DHEA) effects on female libido and sexual arousal in postmenopausal women.
J Womens Health Gend Based Med. 2002 Mar;11(2):155-62.
The age-related decline of DHEA has prompted research on its experimental replacement in women. Although no relationship to female libido functioning in healthy women has been shown to date, DHEA replacement has potential for affecting sexual response. METHODS: To investigate DHEA effects, 16 sexually functional postmenopausal women participated in a randomized, double-blind, crossover protocol in which oral administration of DHEA (300 mg) or placebo occurred 60 minutes before the presentation of an erotic video segment. Blood DHEA sulfate (DHEAS) changes, subjective and physiological sexual responses, as well as affective responses were measured in response to videotaped neutral and erotic video segments. RESULTS: The concentration of DHEAS increased 2-5-fold following DHEA administration in all 16 women. Subjective ratings across DHEA and placebo conditions showed significantly greater mental and physical sexual female libido arousal to the erotic video with DHEA vs. placebo. Positive affect also increased during the erotic video across drug conditions. Vaginal pulse amplitude and vaginal blood volume demonstrated a significant increase between neutral and erotic film segments within both conditions (DHEA and placebo) but did not differentiate drug conditions. CONCLUSION: In sum, increases in mental and physical sexual female libido arousal ratings significantly increased in response to an acute dose of DHEA in postmenopausal women.
Female Libido higher during most fertile days
Biological factors appear to increase the likelihood that a woman will have a higher female libido and engage in sexual intercourse during her most fertile days rather than at other times, according to the results of a new study. Therefore, women who don't want to become pregnancy should be aware that a single episode of unprotected sex may be more risky than chance alone would dictate. In a variety of mammals, intercourse is coordinated with ovulation through different mechanisms, such as an increase in female libido during the fertile period.
Radical hysterectomy seems associated with a disturbed vaginal blood flow response during sexual arousal. This might be related to loss or disruption of nerves to and from the vagina.
Female Libido as part of sexuality in female cancer survivors.
Mayo Clinic Cancer Center, Rochester, MN.
Oncol Nurs Forum. 2004 May;31(3):599-609.
To present the state of knowledge and a suggested program of research related to female libido, one part of sexual functioning in female cancer survivors: female libido. Sexuality is a broadly defined term with many components. Female libido is a component of sexuality and is reviewed with respect to definition, physiology, and measurement. Evidence-based interventions also are discussed. CONCLUSIONS: Most of the evidence related to enhancing female libido involves testosterone, but this has not been tested in cancer survivors. Several clinical questions are yet to be answered regarding physiology as well as nonpharmacologic and pharmacologic interventions for enhancing female libido. Nurse researchers could add much to the evidence base on interventions for improving female libido and, subsequently, sexual health. Implementing behavioral interventions to enhance female libido would be an appropriate nursing function.
The role of androgens in female sexual dysfunction (low female libido).
Shifren JL. Massachusetts General Hospital and Harvard Medical School, Boston, Mass
Mayo Clin Proc. 2004 Apr;79(4 Suppl):S19-24.
There are many treatment options for female sexual dysfunction (low female libido), with the optimal therapy depending on the etiology of the problem. The cause of sexual dysfunction is multifactorial and may include psychological problems such as depression or anxiety disorders, conflict within the relationship, partner performance and technique, issues relating to prior abuse, medical illness, medications, fatigue, stress, or gynecological problems that make sexual activity uncomfortable. The role of low androgen concentrations in low female libido is gaining increasing attention. Available therapeutic options for low female libido include adjusting medications, counseling, treating depression or anxiety, reducing stress and fatigue, sex therapy, devices, estrogen therapy for genitourinary atrophy, and possibly vasoactive substances. Although no androgen therapies are currently approved by the Food and Drug Administration for female sexual dysfunction, they are being used in clinical practice, and early clinical trial results suggest that they may be both effective and safe in the treatment of low female libido. Androgen therapy should be considered primarily in women who have a physiological reason for reduced androgen concentrations, including aging, hypopituitarism, oophorectomy, or adrenal insufficiency. Products in use include oral methyltestosterone and dehydroepiandrosterone (DHEA), topical testosterone ointment, and testosterone implants and injections. Products available for men, including skin patches and gels, are currently being studied at doses appropriate for women. Possible risks include hirsutism, acne, liver dysfunction, lowering of the voice, adverse lipid changes, virilization of a female fetus, and, as androgens are aromatized to estrogens, potentially the risks of estrogen therapy. low female libido.
Predictors of decreased female libido during the late reproductive years.
University of Pennsylvania School of Medicine, Philadelphia, PA.
Menopause. 2004 Mar-Apr;11(2):136-7.
To identify risk factors for decreased female libido among women in the late reproductive years. Prospective cohort. Women aged 35 to 47 years identified through random digit dialing were prospectively followed for 4 years with serial hormone assays and standardized questionnaires. Mean hormone values, hormone trends over 4 years, and fluctuation in hormone levels were compared among women with and without a decrease in libido at the last assessment period. Total testosterone, dihydroepiandrosterone sulfate, estradiol, follicle-stimulating hormone, luteinizing hormone, body mass index, psychosocial, and socioeconomic variables were evaluated using multivariable logistic regression. RESULTS: Of 326 women, 87 (27%) reported a decreased female libido, whereas 239 (73%) did not. Participant-specific means for all hormone levels over the study period were similar among both groups. However, total testosterone fluctuation over the study was significantly different between groups. Women whose testosterone levels fluctuated from 3.8 to 21.5 ng/dL around a mean value of 9 ng/dL were four times more likely to report decreased female libido compared with women with little fluctuation in testosterone, Depression, vaginal dryness, and children living at home were also independently associated with decreased libido. CONCLUSIONS: Decreased female libido in the late reproductive years is associated with a pronounced fluctuation in total testosterone over time. Other independent risk factors for decreased female libido include vaginal dryness, depression, and living with children.
__________________
There are currently 1 users browsing this thread. (0 members and 1 guests)